secwatch / observer
8-K filed June 9, 2023, 7:59 PM ET ticker IMA CIK 0001835579
other confidence high sentiment neutral materiality 0.10

Ikena Oncology shareholders elect three Class II directors, ratify E&Y as auditor

ImageneBio, Inc.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ImageneBio, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-09 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-09
Exact text from the filing
The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 26,385,702 9,069 1,307 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ImageneBio, Inc. shareholders approved Election of Class II Directors: David Bonita, M.D., Jean-François Formela, M.D., and Richard Wooster, Ph.D. at the 2023-06-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-09
Exact text from the filing
The votes cast at the Annual Meeting were as follows: For Withheld Broker Non-Votes David Bonita, M.D. 16,468,374 7,623,868 2,303,836 Jean-François Formela, M.D. 20,781,723 3,310,519 2,303,836 Richard Wooster, Ph.D. 20,784,244 3,307,998 2,303,836
View on SEC.gov

215 shareholder votes filed in the last 30 days. Browse all shareholder votes →

ImageneBio, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-164481
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.